HB 754 requires gender clinics receiving state funding and insurance providers covering gender transition procedures to also offer and cover detransition services (medical or mental health care to reverse or manage effects of transition). It applies specifically to state-funded clinics and insurers, mandating they report detailed statistics on gender transition procedures to the Tennessee Department of Health. The reporting includes patient demographics, procedure types, medications, and diagnoses - while excluding personally identifiable health information. Data must be submitted monthly and compiled into an annual public report starting in 2025. The bill does not restrict access to gender transition care but adds transparency and service parity requirements.
HB 179 modifies Tennessee's criminal abortion law by adding exceptions that exempt certain abortions from criminal prosecution. It specifies that performing an abortion is not a crime if it is necessary to protect the pregnant person's physical or mental health, or if the pregnancy resulted from rape or incest (as defined in Tennessee law). The bill amends Title 39, Chapter 15 of Tennessee Code, reclassifying such abortions as non-criminal under these specific circumstances. This change takes effect July 1, 2025, directly affecting licensed physicians performing abortions and pregnant individuals in these defined situations.
SB 1414, effective May 5, 2025, strengthens Tennessee's alignment with the federal 340B drug discount program by prohibiting drug manufacturers from restricting access to 340B drugs or imposing unfair requirements on participating entities. The bill directly affects 340B entities (such as community health centers and hospitals) and their contracted pharmacies, banning actions like denying 340B drug access, demanding extra health data, or applying stricter audit rules than for non-340B providers. Key provisions require manufacturers to comply with federal 340B rules and prohibit interference with 340B entities' drug choices or contracts. Violations carry a $50,000 civil penalty per violation, enforceable by the state commissioner or attorney general. The law explicitly states it does not override applicable federal 340B regulations.
SB 440 clarifies that standalone dental and vision insurance plans (known as "excepted benefits") are not required to cover specific medical treatments, services, or conditions unless state law explicitly mandates it. This change directly affects health insurance plans offering these stand-alone benefits, removing an implied obligation to cover certain medical needs under those plans. The law applies to all new or renewed insurance policies issued on or after July 1, 2025, ensuring clarity for insurers and policyholders. It does not alter existing coverage requirements for standard health insurance plans.
HB 927 clarifies that certain health insurance benefits (like dental or vision coverage, called "excepted benefits") do not need to be included in standard health insurance plans unless state law explicitly requires them. This affects health insurance providers and policyholders in Tennessee by removing an obligation to cover these specific benefits as part of standard coverage. The bill specifies that excepted benefits are exempt from requirements to cover specific people, providers, treatments, or conditions unless mandated by law. It applies to new or renewed insurance policies on or after July 1, 2025.
SB 449, the "Fertility Treatment and Contraceptive Protection Act," establishes legal rights for individuals in Tennessee to access fertility treatments and contraception without state prohibition. It defines "fertility treatment" broadly to include procedures like in vitro fertilization, genetic testing of embryos, and medication for fertility, while defining "contraception" to cover methods such as birth control pills, emergency contraceptives, and sterilization. The law explicitly states that Tennessee law does not prohibit these activities, overriding conflicting state laws. This act takes effect on July 1, 2025, directly affecting all residents seeking these health services within the state.
HB 1044, now Public Chapter 266, enacts Tennessee's "Medical Ethics Defense Act" to protect healthcare providers' rights to refuse care based on conscience. It prohibits discrimination against providers who decline to participate in specific procedures (like certain reproductive or end-of-life care) that conflict with their ethical, moral, or religious beliefs, as defined in the law. The bill also shields providers from retaliation for reporting violations of these protections or disclosing concerns about patient safety. It explicitly excludes federal laws like EMTALA and religious institutions' employment decisions from its scope.
HB 1198 requires Tennessee health insurers and TennCare to allow patients to try biosimilar drugs (cost-effective copies of brand-name medications) before covering the original branded drug. It amends state law to permit health carriers to mandate a biosimilar trial for equivalent branded prescriptions, removing prior requirements for generic drug trials. The bill also directs TennCare’s pharmacy committee to consider biosimilar drugs when recommending medications for the state’s preferred drug list. These changes aim to reduce prescription drug costs by increasing biosimilar adoption, as stated in the bill’s legislative findings.
HB 1074 removes two notification requirements related to prior authorization for healthcare services in Tennessee. It eliminates the obligation for healthcare providers to inform patients when communicating with insurers about missing information for prior authorization requests, and it removes the requirement for utilization review organizations to notify patients when providers fail to submit needed information within seven days. The bill directly affects patients, healthcare providers, and insurance entities by changing communication protocols during the prior authorization process. These changes amend Tennessee Code Sections 63-1-171(b) and 56-6-705(a), effective upon becoming law (Public Chapter 125, enacted April 8, 2025).
SB 1063 removes two notification requirements related to prior authorization for healthcare services in Tennessee. It eliminates the requirement for healthcare providers to notify patients when communicating with insurance companies about missing information for prior authorization, and it removes the requirement for insurance companies to notify patients when additional information is needed from the patient or provider. The bill directly affects healthcare providers, insurance companies, and patients by reducing administrative steps in the prior authorization process. These changes amend Tennessee Code sections 63-1-171 and 56-6-705, effective April 3, 2025.
